Plethora Solutions Holdings Plc - Strategic SWOT Analysis Review

April 2018 | 21 pages | ID: P8D4D1E9C5AEN
GlobalData

Abstracts

Plethora Solutions Holdings Plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – GlobalData’s summarization of the company’s business strategy.
• SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
• Key manufacturing facilities – A list of key manufacturing facilities of the company.

Highlights

Plethora Solutions Holdings plc (Plethora), a subsidiary of Regent Pacific is a pharmaceutical company which develops and markets products for the treatment and management of urological disorders. It focuses on the development of medicines for the treatment of urology and sexual health. The company’s lead product candidate is Fortacin, a metered-dose aerosol formulation of lidocaine and prilocaine. It is topical product for the treatment of premature ejaculation. The product has received marketing approval in Europe. The company has partnerships with companies such as Recordati and Pharmaserve among others. Plethora is headquartered in Chalgrove, Oxfordshire, the UK.

Reasons to Buy

• Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
• Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
• Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
• Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

Contents

SECTION 1 - ABOUT THE COMPANY

Plethora Solutions Holdings Plc - Key Facts
Plethora Solutions Holdings Plc - Key Employees
Plethora Solutions Holdings Plc - Key Employee Biographies
Plethora Solutions Holdings Plc - Major Products and Services
Plethora Solutions Holdings Plc - History
Plethora Solutions Holdings Plc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
Plethora Solutions Holdings Plc - Business Description
Plethora Solutions Holdings Plc - SWOT Analysis
SWOT Analysis - Overview
Plethora Solutions Holdings Plc - Strengths
Plethora Solutions Holdings Plc - Weaknesses
Plethora Solutions Holdings Plc - Opportunities
Plethora Solutions Holdings Plc - Threats
Plethora Solutions Holdings Plc - Key Competitors

SECTION 3 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Plethora Solutions Holdings Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Plethora Solutions Holdings Plc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
Plethora Solutions Holdings Plc, Recent Deals Summary

SECTION 4 – APPENDIX

Methodology
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Plethora Solutions Holdings Plc, Key Facts
Plethora Solutions Holdings Plc, Key Employees
Plethora Solutions Holdings Plc, Key Employee Biographies
Plethora Solutions Holdings Plc, Major Products and Services
Plethora Solutions Holdings Plc, History
Plethora Solutions Holdings Plc, Subsidiaries
Plethora Solutions Holdings Plc, Key Competitors
Plethora Solutions Holdings Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Plethora Solutions Holdings Plc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
Plethora Solutions Holdings Plc, Recent Deals Summary

List Of Figures

LIST OF FIGURES

Plethora Solutions Holdings Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Plethora Solutions Holdings Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018

COMPANIES MENTIONED

Vectura Group Plc
Pfizer Inc
Nanoform Cardiovascular Therapeutics Ltd
Janssen-Cilag Ltd
Futura Medical Plc